Blue Dart MD Balfour Manuel steps down, R.S. Subramanian named successor

CEO resignedExternal CEO appointedManagement Changes View source PDF Explain this filing

BLUEDART · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.9%Reaction day

₹4810.80

prior close

₹4808.50

announcement price

After-mkt

timing

Nifty Smallcap 250market-0.2%+1.1% vs market

Logistics Solution Provider peers, median of 44sector+0.0%+0.9% vs sector

On the reaction day the stock moved 1.1 pts more than Nifty Smallcap 250 and 0.9 pts more than its Logistics Solution Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.0

10m

-0.1

15m

-0.5

30m

-1.3

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.9-0.2+1.1+0.0+0.9

Next day

+0.0+0.7-0.6+0.4-0.4

-0.0+2.2-2.2-0.3+0.2

-0.3+2.2-2.4-0.1-0.1

-0.6+2.1-2.7-0.3-0.3

-0.2+2.9-3.1+0.4-0.7

-1.7+1.5-3.2+0.6-2.2

15d

-5.2-2.3-3.0-4.4-0.9

-8.3-1.4-6.9-3.0-5.3

—————

UpDownMarket · Nifty Smallcap 250Sector · Logistics Solution Provider peers, median of 44Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Blue Dart Express MD Balfour Manuel will take early superannuation on Nov 29, 2026, ending his 43-year tenure. He will serve as Sr. Strategic Advisor until May 15, 2027. R.S. Subramanian, current MD of DHL Express India and Blue Dart Non-Executive Director since 2019, will take over as MD from Nov 30, 2026 to May 25, 2030, subject to shareholder approval. The transition is planned for smooth succession.

Likely market impact

Planned leadership change within DHL group, continuity expected. No negative material reasons cited. Watch shareholder approval for new MD.